Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

New world results for diabetes drug dapagliflozin

October 6, 2022
admin
Results from the first retrospective observational study of people with type 2 diabetes (T2D) treated with dapagliflozin (Forxiga) in routine UK primary care were presented at the 51st Congress of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden.

Cancers are being diagnosed earlier in England

October 6, 2022
admin
The proportion of cancers diagnosed as a result of emergency presentation at hospital has decreased. At the same time, the proportion of cancers diagnosed through urgent GP referral with a suspicion of cancer (known as the two week wait) has increased.

Spotlight: baldness and alopecia

October 6, 2022
admin
In this article Associate Professor Mehmet Veli Karaaltin from Acibadem Hospitals Group looks at issues around baldness and alopecia and considers the available treatments

More GPs needed in Northern Ireland to cut spiralling waiting times

October 6, 2022
admin
Northern Ireland needs more GPs to cut spiralling waiting lists, and to enable family doctors to spend more time with patients, according to the Royal College of General Practitioners in Northern Ireland (RCGPNI).

England could have lowest disease burden in the world, new research reveals

October 6, 2022
admin
England could have the lowest disease burden in the world €“ that is years of life lost to death and lived with disability €“ a new Public Health England study has revealed.

Invest in social care to address unmet needs of the elderly says Age UK

October 6, 2022
admin
New analysis by Age UK reveals that Government investment of an additional sum equivalent to less than 4% of the annual NHS budget of £112bn per annum would address the unmet care needs of the million plus aged 65+ who are currently struggling to cope on their own - and help sustain the NHS at the same time.

Youngsters using e-cigarettes more likely to go on to smoke, research finds

October 6, 2022
admin
Nearly 40% of teenagers who used e-cigarettes went on to smoke real cigarettes, new research published in JAMA Pediatric has revealed.

NICE looks to make new treatment development more efficient

October 6, 2022
admin
NICE is to partner with a number of organisations as part of a new public-private project which aims to identify activities that can make the development and regulation of medicines more efficient.

Two new subtypes of pancreatic cancer discovered

October 6, 2022
admin
Scientists have discovered two new subtypes of pancreatic cancer, as well as new types of stroma €“ dense surrounding tissue that can block drugs from reaching pancreatic tumours but that can also prevent the cancer from spreading.

Breakthrough in fighting liver disease

October 6, 2022
admin
The University of Brighton has announced it is sharing in a ‚¬5.9m EU grant to support the development of a new treatment for chronic liver disease as part of a European consortium led by University College London.

NICE approves a new option for rheumatoid arthritis

October 6, 2022
admin
NICE has issued a positive Final Appraisal Determination (FAD) recommending RoActemra intravenous (IV) monotherapy for patients with severe rheumatoid arthritis (RA) for use on the NHS.

Could aspirin boost cancer immunotherapy?

October 6, 2022
admin
Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell.

Bedaquiline to be made available on NHS to tackle drug resistant tuberculosis in England

October 6, 2022
admin
A new Clinical Commissioning Policy issued by NHS England means Sirturo (bedaquiline) will be made routinely available to tackle the increasing number of multi-drug resistant tuberculosis cases in England.

Naturally dissolving stent shows promising trial results

October 6, 2022
admin
A stent that dissolves leaving behind a restored vessel free of a permanent implant, with the potential to flex, pulse and dilate in response to various demands on the heart, has received a positive response following a trial in Japan.

New drug significantly reduces LDL-C cholesterol

October 6, 2022
admin
A new pooled analysis of heterozygous familial hypercholesterolaemia (HeFH) patients included in the ODYSSEY clinical trial programme found that alirocumab significantly reduced low-density lipoprotein cholesterol (LDL-C)

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy